Tongue Muscular Assessment in Healthy Children
Condition(s) studied
Investigational drug(s) / intervention(s)
Sleep quality assessment: The following item will be assessed in all subjects (n=420): 1\. Sleep, through the Pediatric Sleep Questionnaire.
Anthropometry: The following items will be assessed in all subjects (n=420): 2\. Anthropometric data : 2.1 Height; 2.2 Weight; 2.3 Maximal mouth opening; 2.4 Maximal mouth opening with tongue to palate (with the Quick Tongue-Tie assessment tool)
Tongue strength assessment: The following items will be assessed in all subjects (n=420): 3\. Tongue pressure (in kPa) exerted against the IOPI (Iowa Oral Performance Instrument) bulb while swallowing. 4\. Tongue peak pressure (i.e., the maximal pressure - Pmax - exerted against the IOPI bulb) during 3 sec. of tongue elevation. 5\. Tongue peak pressure during 3 sec. of tongue protrusion.
Tongue endurance assessment: The following items will be assessed in all subjects (n=420): 6\. The tongue endurance (i.e., the time to task failure in maintaining a pressure equal to 50%Pmax against the IOPI bulb) during tongue elevation. 7\. The tongue endurance during tongue protrusion.
Orofacial praxis assessment: \- The following item will be assessed in a subset of subjects (n=31): 8. Orofacial praxis through the Motricité Bucco-Linguo-Faciale (MBLF) test.
Study summary
This study aims to obtain normative values for tongue motor functions in healthy children.
Eligibility
Primary outcome measure(s)
- Tongue peak pressure during elevation and protrusion movements — At baseline
Tongue peak pressure during elevation and protrusion movements will be measured via the IOPI (Iowa Oral Performance Instrument) device
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cliniques universitaires Saint-Luc | Woluwe-Saint-Lambert | Belgium | Recruiting |
More Université Catholique de Louvain trials in Belgium
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06166680 on ClinicalTrials.gov ↗ ← All trials in Belgium